Why the study?
Do 1-year survivors of aneurysmal subarachnoid hemorrhage have long-term excess mortality compared to a matched general population?
Do 1-year survivors of aneurysmal subarachnoid hemorrhage have long-term excess mortality compared to a matched general population?
Survivors of aneurysmal subarachnoid hemorrhage experience long-term excess mortality, particularly from cardiovascular and cerebrovascular events, highlighting the need for active management of vascular risk factors.
Answers are grounded in this paper and cite their sources.
Excess mortality persists long-term after aSAH; leaves open whether multiple-aneurysm patients need intensified surveillance or intervention trials.
BACKGROUND AND PURPOSE: There is high case-fatality rate and loss of productive life-years related to aneurysmal subarachnoid hemorrhage (aSAH) but data on long-term survival of patients with aSAH are scarce. We aim to evaluate long-term excess mortality and related risk factors after an aSAH event. METHODS: Survivors (n=3078) of aSAH who had survived for ≥1 year were reviewed for this retrospective follow-up study, which was conducted in the Department of Neurosurgery in Helsinki between 1980 and 2007. Follow-up started 1 year after the aSAH and continued until death or the end of 2012 (48 918 patient-years). Mortality and relative survival ratios were derived using a matched general population. RESULTS: Survivors of aSAH after 20 years showed 17% excess mortality compared with the general population. Even young patients and patients with good recovery showed excess mortality. The highest excess mortality was among patients with multiple aneurysms, old age, poor preoperative clinical condition, conservative aneurysm treatment, and unfavorable clinical outcome at 1 year. CONCLUSIONS: Even after initially favorable recovery from an aSAH, survivors experience excess mortality in the long run in comparison to a matched general population. Cardiovascular disease at younger age and cerebrovascular events were overrepresented as causes of death, which indicates the importance of treatment of vascular risk factors. Young patients and patients with multiple aneurysms who are recovering from an aSAH should be followed-up and treated most actively.
No takes yet. Share an insight, caveat, or question.
Huhtakangas et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: